SEC Form 4/A · accession 0001209191-18-063965
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Lauren M Sabella
Officer — Chief Commercial Officer
Period of report
Jun 28, 2018
Accepted (ET)
Dec 21, 2018 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 28, 2018 | S | 3,774 | $27.84 | D | 7,391 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 2, 2018, the reporting person filed a Form 4 reporting the June 28, 2018 sale of 5,859 shares of common stock pursuant to a Rule 10b5-1 plan. The report person's broker subsequently acknowledged that of the 5,859 shares, 2,085 were erroneously sold by the broker. The sale of the 2,085 shares was unwound through the broker's error account and therefore did not occur for purposes of the reporting person's account. This Form 4 amends and restates, in its entirety, the transaction reported in the July 2, 2018 Form 4 in order to correctly report the disposition of 3,774 shares of the issuer's common stock pursuant to the reporting person's Rule 10b5-1 plan.
- F2The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $27.45 to $28.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3As a result of the overstatement of the number of shares sold on the reporting person's July 2, 2018 Form 4, the reporting person's subsequently filed Form 4s have understated her ownership of the issuer's common stock by 2,085 shares. As of the date of this amendment, the reporting person directly holds 3,653 shares of the issuer's common stock.